PPLPHARMA
Piramal Pharma Limited
Pharmaceuticals · ₹22,886 Cr market cap
A pharmaceutical company operating across three major segments: contract development and manufacturing organisations, complex hospital generics for critical care, and consumer healthcare products. Established through the acquisition of Nicholas Laboratories in 1988, the company has expanded via strategic mergers and acquisitions alongside organic growth initiatives. It serves healthcare providers and consumers across India through its diversified business operations and specialized pharmaceutical solutions.
1
Tracked investors holding
0
Tracked moves
₹172
Share price
Top investors holding Piramal Pharma Limited
2.00%
Track smart money in Piramal Pharma Limited
Get alerted when a top investor buys or sells.
Get started